Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
- March -
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
- 2014 -
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
March 2014 - 33 products
L
IP
CI
PP
Elvanse 20 mg
30
80.84
101.85
10 %
Capsules: Lisdexamfetamini Dimesilas 20 mg
Takeda Pharma AG
A+ / SL / SO
FB
G
L
IP
CI
PP
Elvanse 30 mg
30 Capsule(s)
86.89
108.25
10 %
Capsules: Lisdexamfetamini Dimesilas 30 mg
Takeda Pharma AG
A+ / SL / SO
FB
G
L
IP
CI
PP
Elvanse 40 mg
30
93.29
115.00
10 %
Capsules: Lisdexamfetamini Dimesilas 40 mg
Takeda Pharma AG
A+ / SL / SO
FB
G
L
IP
CI
PP
Elvanse 50 mg
30 Capsule(s)
99.69
121.75
10 %
Capsules: Lisdexamfetamini Dimesilas 50 mg
Takeda Pharma AG
A+ / SL / SO
FB
G
L
IP
CI
PP
Elvanse 60 mg
30
107.18
129.70
10 %
Capsules: Lisdexamfetamini Dimesilas 60 mg
Takeda Pharma AG
A+ / SL / SO
FB
G
L
IP
CI
PP
Elvanse 70 mg
30 Capsule(s)
114.64
137.55
10 %
Capsules: Lisdexamfetamini Dimesilas 70 mg
Takeda Pharma AG
A+ / SL / SO
FB
G
L
IP
CI
Rivastigmin Zentiva Patch 4.6
mg/24 h
30
39.51
59.40
10 %
Transdermal patch: Rivastigminum 6.9 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Rivastigmin Zentiva Patch 9.5
mg/24 h
30
39.51
59.40
10 %
Transdermal patch: Rivastigminum 13.8 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Rivastigmin Zentiva Patch 9.5
mg/24 h
2 x 30
79.02
102.35
10 %
Transdermal patch: Rivastigminum 13.8 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
Rivastigmin Zentiva Patch
13.3 mg/24 h
30
39.51
59.40
10 %
Transdermal patch: Rivastigminum 19.2 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
Rivastigmin Zentiva Patch
13.3 mg/24 h
2 x 30
79.02
102.35
10 %
Transdermal patch: Rivastigminum 19.2 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Memantin-Mepha 5 mg
Kombipackung(en)
27.61
46.45
10 %
Coated tablets: Memantini Hydrochloridum
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Memantin-Mepha 10 mg
50 Tablet(s)
43.64
63.90
10 %
Coated tablets: Memantini Hydrochloridum
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Memantin-Mepha 20 mg
98 Tablet(s)
166.52
197.50
10 %
Coated tablets: Memantini Hydrochloridum
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
CM
Celecoxib Viatris 100 mg
30
9.07
26.25
10 %
Capsules: Celecoxibum 100 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
CM
Celecoxib Viatris 200 mg
30
14.86
32.55
10 %
Capsules: Celecoxibum 200 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
CM
Celecoxib Viatris 200 mg
100
46.27
66.60
10 %
Capsules: Celecoxibum 200 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
Ganfort Unit Dose
30 x 0.4 ml
23.46
41.95
10 %
Eye drops: 2 Active Agents
AbbVie AG
B / SL
FB
G
IP
CI
Ganfort Unit Dose
90 x 0.4 ml
66.85
89.10
10 %
Eye drops: 2 Active Agents
AbbVie AG
B / SL
FB
G
IP
CI
PP
Acnatac
30 g
15.14
32.90
10 %
Gel: 2 Active Agents
Viatris Pharma GmbH
A / SL
FB
G
IP
CI
CM
Metofol 5mg
100 Tablet(s)
5.25
14.95
10 %
Tablets: Acidum Folicum 5 mg
Gebro Pharma AG
B / SL
FB
G
IP
CI
Memantin-Mepha 15 mg
Kombipackung(en)
PR
PR
k.A.
Coated tablets: Memantini Hydrochloridum
Mepha Pharma AG
B
FB
G
IP
CI
Memantin-Mepha 10 mg
100 Tablet(s)
PR
PR
k.A.
Coated tablets: Memantini Hydrochloridum
Mepha Pharma AG
B
FB
G
IP
CI
Memantin-Mepha 20 mg
140 Tablet(s)
PR
PR
k.A.
Coated tablets: Memantini Hydrochloridum
Mepha Pharma AG
B
FB
G
IP
CI
PP
Sovaldi 400 mg
28 Tablet(s)
14332.50
14936.80
k.A.
Coated tablets: Sofosbuvirum 400 mg
Gilead Sciences
Switzerland Sàrl
A
FB
G
IP
CI
CM
Metofol 5mg
20 Tablet(s)
5.25
14.20
k.A.
Tablets: Acidum Folicum 5 mg
Gebro Pharma AG
B
FB
G
IP
PP
Jetrea
0.5 ml
3170.08
3495.35
k.A.
Ocriplasminum
mmpharm GmbH
B
FB
G
IP
Amikacin B. Braun 2.5
mg/ml
10 x 100 ml
PR
PR
k.A.
Infusion solution: Amikacinum 250mg / 100ml
B. Braun Medical AG
A
FB
G
IP
Amikacin B. Braun 2.5
mg/ml
20 x 100 ml
PR
PR
k.A.
Infusion solution: Amikacinum 250mg / 100ml
B. Braun Medical AG
A
FB
G
IP
Amikacin B. Braun 5 mg/ml
10 x 100 ml
PR
PR
k.A.
Infusion solution: Amikacinum 500mg / 100ml
B. Braun Medical AG
A
FB
G
IP
Amikacin B. Braun 5 mg/ml
20 x 100 ml
PR
PR
k.A.
Infusion solution: Amikacinum 500mg / 100ml
B. Braun Medical AG
A
FB
G
IP
Amikacin B. Braun 10
mg/ml
10 x 100 ml
PR
PR
k.A.
Infusion solution: Amikacinum
B. Braun Medical AG
A
FB
G
IP
Amikacin B. Braun 10
mg/ml
20 x 100 ml
PR
PR
k.A.
Infusion solution: Amikacinum
B. Braun Medical AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home